Gene · 9619
NIH grants2,320
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 2,320
Download this page as JSON| Grant | Title | ABCG1 papers | Newest fiscal year |
|---|---|---|---|
| P50AA024333 | Alcohol and tissue injury, from mechanisms to treatments | 2 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 2 | 2025 |
| R01AG050986 | Higher Order Chromatin and Genetic Risk for Alzheimer's Disease | 2 | 2025 |
| R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 2 | 2025 |
| R01CA194057 | Transporters and Medulloblastoma | 2 | 2025 |
| R01DE031206 | Trained innate immunity and periodontitis-associated comorbidities | 2 | 2025 |
| R01DK102619 | Mechanisms Underlying the Pathogenesis of Non-alcoholic Fatty Liver Disease | 2 | 2025 |
| R01DK115679 | Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions | 2 | 2025 |
| R01EY012601 | Hematopoietic cell mobilization from distinct bone marrow compartments following retinal injury | 2 | 2025 |
| R01EY016077 | Dyslipidemia and Diabetic Retinopathy | 2 | 2025 |
| R01EY017017 | Dietary control of angiogenesis in retinopathy models | 2 | 2025 |
| R01EY026964 | Targeting NAD metabolism to ameliorate bacterial endophthalmitis | 2 | 2025 |
| R01EY027381 | Ferroptosis in bacterial endophthalmitis: Mechanisms and Therapeutic targeting | 2 | 2025 |
| R01GM147545 | Development of a Novel Technology for Preparative Fractionation and Characterization of Lipoprotein Particles | 2 | 2025 |
| R01HG002385 | Long-read sequence and assembly of segmental duplications | 2 | 2025 |
| R01HL072304 | Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism | 2 | 2025 |
| R01HL133216 | Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease | 2 | 2025 |
| R01HL155095 | Airway Structural Cells and Corticosteroid Resistance in Asthma | 2 | 2025 |
| R01HL162367 | The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | 2 | 2025 |
| R35GM150836 | Methods for leveraging family-based designs and summary data to elucidate complex trait genetics | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9619/grants?page=5